Dow Jones 30 Stocks SEC Filings — April 14, 2026

14-04-2026

Sportsman’s Warehouse Holdings, Inc. (SPWH) has filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders, to be held virtually on May 27, 2026, at 8:00 a.m. Mountain Time, with a record date of April 2, 2026. Key proposals include electing six director nominees, advisory approval of named executive officer compensation, approving a second amendment to the Amended and Restated 2019 Performance Incentive Plan to increase shares available for grants, ratifying Grant Thornton LLP as independent auditors for fiscal year 2026, and an advisory vote on the frequency of future say-on-pay votes (Board recommends 1 year). No specific financial performance metrics or period-over-period comparisons are provided in the filing excerpt.

• ·Annual Meeting accessible via www.virtualshareholdermeeting.com/SPWH2026 using control number from proxy card.
• ·Proxy materials and 2025 Form 10-K for fiscal year ended January 31, 2026, mailed on or about April 14, 2026.
• ·Principal executive offices: 1475 West 9000 South, Suite A, West Jordan, Utah 84088.
• ·Stockholder list available for examination 10 days prior to meeting at principal offices.

14-04-2026

Johnson & Johnson reported Q1 2026 sales of $24.1 Billion, up 9.9% reported (6.4% operational, 5.3% adjusted operational), with Innovative Medicine up 7.4% operational and MedTech up 4.6% operational, driven by products like DARZALEX, CARVYKTI, and TREMFYA but offset by declines from STELARA (-9.2% impact) and IMBRUVICA. However, GAAP net earnings fell 52.4% to $5.2 Billion and adjusted EPS declined 2.5% to $2.70, with free cash flow dropping to ~$1.5 Billion from $3.4 Billion. The company raised full-year 2026 guidance to $100.8 Billion reported sales (7.0% growth midpoint) and adjusted EPS of $11.55 (7.1% growth midpoint), amid multiple product approvals including ICOTYDE and TECVAYLI plus DARZALEX FASPRO.

• ·Innovative Medicine growth positively impacted by net acquisitions/divestitures +1.8% (primarily CAPLYTA)
• ·MedTech divestitures negatively impacted growth by -0.1%
• ·U.S. sales +8.3% operational; International operational +3.9%
• ·FDA approvals include ICOTYDE for plaque psoriasis, TECVAYLI + DARZALEX FASPRO for multiple myeloma, VARIPULSE Pro in Europe
• ·Planned Enterprise Business Review on December 8, 2026

14-04-2026

Regent Peak Wealth Advisors LLC filed a 13F-HR report on April 14, 2026, disclosing total holdings of $490,319,320 across 198 positions as of March 31, 2026. The portfolio is diversified with top holdings including Apple Inc. ($27,373,382, 107,858 shares), Vanguard Total Bond Market ETF ($24,768,437, 336,345 shares), and Nvidia Corporation ($15,459,178, 88,642 shares). All reported positions have sole voting authority, with no period-over-period changes disclosed in the filing.

• ·Filing period end date: 2026-03-31
• ·All holdings reported as sole discretionary voting authority (SH SOLE)

14-04-2026

Davies Financial Advisors, Inc. disclosed total holdings of $10,917,105 across 11 positions as of March 31, 2026, in its quarterly 13F-HR filing submitted on April 14, 2026. The portfolio is heavily weighted toward ETFs including Invesco QQQ Trust ($4,632,699, top holding) and SPDR S&P 500 ETF Trust ($1,581,692), with additional exposure to tech stocks like Apple ($430,936) and Microsoft ($531,934). No changes or prior period comparisons were reported.

• ·All holdings reported with sole voting power and no shared power, puts, or calls.
• ·Filing covers period ending March 31, 2026.

14-04-2026

Evernorth Holdings Inc. issued a Form 425 filing on April 14, 2026, disclosing communications related to its proposed business combination with Armada Acquisition Corp. II (SPAC) and Pathfinder Digital Assets LLC, originally agreed via Business Combination Agreement on October 19, 2025. A registration statement, including a preliminary proxy statement/prospectus, was filed with the SEC on March 18, 2026, in connection with the merger, private placements, and related transactions. While forward-looking statements highlight ambitions like building an institutional XRP treasury and Nasdaq listing, the filing extensively lists risks including deal failure, regulatory issues, XRP volatility, and high redemptions that could prevent completion or benefits.

• ·Business Combination Agreement dated October 19, 2025
• ·Registration Statement filed with SEC on March 18, 2026
• ·Armada II prospectus dated May 20, 2025, filed May 21, 2025
• ·Armada II Form 10-Q filed August 11, 2025
• ·Contact: Armada Acquisition Corp. II, 382 NE 191st St., Suite 52895, Miami, Florida 33179-3899; finance@arringtoncapital.com
• ·Contact: Evernorth Holdings Inc., 600 Battery St, San Francisco, CA 94111; finance@evernorth.xyz

14-04-2026

Bank of Finland filed a 13F-HR report on April 14, 2026, disclosing its holdings as of March 31, 2026, in four ETFs with a total market value of $1,366,372,990. The largest holding is DBX ETF TR XTRACKERS MSCI valued at $422,341,035 (10,822,209 shares), followed by ISHARES TR CORE S&P500 ETF at $342,000,506 (523,569 shares). No changes in holdings or performance metrics were reported in this quarterly snapshot.

• ·CUSIP for ISHARES TR CORE MSCI INTL: 46435G326
• ·CUSIP for ISHARES TR CORE S&P500 ETF: 464287200
• ·CUSIP for ISHARES TR PARIS ALIGNED CL: 46436E411
• ·CUSIP for DBX ETF TR XTRACKERS MSCI: 23306X605
• ·All holdings reported as sole ownership with full voting authority

14-04-2026

Runnymede Capital Advisors, Inc. filed its 13F-HR report for the quarter ended March 31, 2026, disclosing a total portfolio value of $116.4 billion across 75 holdings, heavily concentrated in technology and leveraged ETFs. Top positions include ProShares Ultra Technology UIT Exchange Traded ($11.97B), Invesco QQQ TR UIT Exchange Traded ($7.82B), NVIDIA Corp ($7.15B), Alphabet Inc ($6.70B), and Amazon.com Inc ($6.68B). The portfolio also features significant allocations to Apple ($6.26B), Microsoft ($5.65B), and crypto-related ETFs like Grayscale Bitcoin Trust ($639M).

• ·Filing date: April 14, 2026
• ·Report period end date: March 31, 2026
• ·All positions reported as sole ownership with no shared or other voting authority

14-04-2026

Arcadia Investment Advisors LLC filed a 13F-HR report disclosing 81 equity positions totaling $211813007 as of March 31, 2026, all held under sole investment discretion with no reported changes, shared holdings, or other voting authority. The portfolio is diversified across individual stocks and ETFs, with top holdings including Schwab Strategic TR US Lrg Cap ETF at $12933355, SPDR Index Shs Fds State Street Spd (78463X848) at $11380155, and American Cnty ETF Tr Avantis US LARG at $11032341. No period-over-period comparisons are provided in the filing.

• ·All positions held with sole voting authority.
• ·No put/call options or other manager discretion reported.
• ·Filed on April 14, 2026 for period ending March 31, 2026.

14-04-2026

Unity Bancorp reported Q1 2026 net income of $14.3 million ($1.40 per diluted share), down 7.7% QoQ from $15.5 million ($1.52) due to lower net interest income ($30.7 million, -2.0%) and noninterest income ($2.9 million, -25.6%), though up 23.2% YoY from $11.6 million amid 12.8% YoY NII growth. Balance sheet showed growth with gross loans up 2.2% QoQ ($2,601.7 million) and 10.9% YoY, deposits up 2.4% QoQ ($2,379.1 million), and shareholders' equity up 3.6% to $358.1 million, while noninterest expense rose 6.0% QoQ to $14.1 million. Capital ratios improved slightly QoQ, nonaccrual assets ticked up 2.5% to $32.1 million, and the company announced a 7% dividend increase to $0.16 per share.

• ·Provision for credit losses decreased 52.8% QoQ to $1.0 million.
• ·Uninsured/uncollateralized deposits at 21.6% of total deposits as of March 31, 2026.
• ·Named one of Piper Sandler’s Top Bank Investment Ideas for 2026.
• ·Annual shareholder meeting scheduled for April 23, 2026 at 8:00 AM EDT.
• ·Total assets $3.0 billion, with $229.2 million cash and cash equivalents.

14-04-2026

Serve Robotics Inc. completed its acquisition of Diligent Robotics, Inc. on January 27, 2026, via a merger agreement dated January 19, 2026. This 8-K/A amendment provides Diligent's audited 2025 financials, which show revenue of $9,044 thousand but a gross loss of $1,385 thousand due to cost of revenues exceeding revenue, alongside a net loss of $22,708 thousand driven by high operating expenses of $18,936 thousand. Diligent reported total assets of $13,436 thousand but carried a stockholders' deficit of $110,240 thousand and significant current liabilities of $17,285 thousand exceeding current assets.

• ·Diligent's operating expenses breakdown: General and administrative $5,653 thousand, Operations $2,811 thousand, Research and development $6,789 thousand, Sales and marketing $3,683 thousand.
• ·Other expenses include interest expense net $1,319 thousand, loss on extinguishment of SVB Loans $74 thousand, loss on issuance of Bridge Loans $1,100 thousand ($600 thousand to related parties).
• ·Auditor consent from dbbmckennon dated April 13, 2026.
• ·Pro forma condensed combined financial statements of Serve as of December 31, 2025 filed as Exhibit 99.2.

14-04-2026

Travere Therapeutics, Inc. announced on April 13, 2026, that the FDA approved FILSPARI (sparsentan) to reduce proteinuria in adult and pediatric patients aged 8 years and older with FSGS without nephrotic syndrome, marking the first FDA-approved medicine for FSGS and expanding beyond IgAN. In the Phase 3 DUPLEX Study (n=371), FILSPARI achieved a statistically significant 46% proteinuria reduction from baseline to Week 108 vs. 30% for irbesartan (p=0.0299) overall, and 48% vs. 27% (p=0.0075) in non-nephrotic patients, with a 1.1 mL/min/1.73 m² eGFR benefit. The U.S. addressable population is estimated at more than 30,000 individuals.

• ·DUPLEX Study: global, randomized, double-blind trial in patients ages 8-75 with biopsy-proven or genetic FSGS; primary endpoint was eGFR change from baseline to Week 108.
• ·eGFR treatment difference in non-nephrotic patients: 1.1 mL/min/1.73 m² (FILSPARI -11.3 vs. irbesartan -12.4).
• ·Nephrotic syndrome defined as proteinuria >3.5 g/24h (adults) or UPCR >2.0 g/g (pediatrics), serum albumin <3.0 g/dL, and edema.
• ·FILSPARI generally well tolerated with safety profile comparable to irbesartan.

14-04-2026

On April 6, 2026, Dan Leboffe resigned from the Board of Directors of Cyber Enviro-Tech, Inc. (CETI) effective immediately, transitioning to the company's Advisory Board. Concurrently, Brianna Stoecklein, CEO of AirPower USA (CETI's exclusive manufacturing and distribution partner), was appointed to the Board effective immediately to strengthen strategic alignment. Ms. Stoecklein brings over 17 years of executive experience in operations, client relations, and advanced energy technologies commercialization.

• ·CETI trades as CETI on OTCQB.
• ·CETI is an emerging growth company.
• ·Exhibit 17.1: Resignation Letter of Dan Leboffe.

14-04-2026

XCF Global, Inc. (SAFX) entered into a definitive Business Combination Agreement on April 13, 2026, with DevvStream Corp. and Southern Energy Renewables Inc., structured as mergers where both targets will become wholly-owned subsidiaries in exchange for Company Common Shares, following a prior term sheet from January 26, 2026. The deal advances strategic growth in renewables but remains subject to extensive closing conditions including shareholder approvals, regulatory clearances, fairness opinions, $400M Louisiana bond issuance approval, $10M minimum cash, $1B annualized revenue target by June 30, 2026, and execution of key offtake agreements. Termination fees range from $510,000 to $1.19M apply in certain scenarios, with an Outside Date approximately 10 months from signing.

• ·Fairness opinions required within 20 Business Days of BCA signing, with termination rights if not received.
• ·Outside Date is 10 months from April 13, 2026, with possible 30-day extension.
• ·Southern shareholder approval already obtained prior to BCA execution.
• ·DevvStream equity awards (warrants, options, RSUs, convertible notes) to convert into Company Common Shares.

14-04-2026

DevvStream Corp. entered into a definitive Business Combination Agreement on April 13, 2026, with XCF Global, Inc. and Southern Energy Renewables Inc., structuring mergers where DevvStream (post-domestication to Delaware) and Southern become wholly-owned subsidiaries of XCF, subject to shareholder approvals, regulatory clearances, and fairness opinions. Key conditions include Southern securing approval for at least $400,000,000 in Louisiana bonds, $10,000,000 in cash/funding, SAF and European Offtake Agreements, and XCF achieving over $1,000,000,000 annualized revenue and $100,000,000 EBITDA by June 30, 2026, with termination fees of $510,000 and potential expense reimbursements up to $170,000 highlighting execution risks. The deal advances prior term sheet terms but faces substantial closing hurdles and no assurances of completion.

• ·Outside Date: 10 months from BCA date (April 13, 2026), extendable by 30 days by mutual agreement
• ·Fairness opinions (Company and XCF) required within 20 Business Days of BCA, non-delivery allows termination
• ·Southern Shareholders pre-approved the Mergers, so their approval not a closing condition
• ·Company equity awards (Warrants, Options, RSUs, Convertible Notes) to convert into XCF equivalents

14-04-2026

Avanos Medical, Inc. (NYSE: AVNS) has entered a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an all-cash transaction valuing the enterprise at approximately $1.272 billion, with stockholders to receive $25.00 per share, a 72.1% premium to the April 13, 2026 closing price and 82.8% to the 30-day VWAP. The deal, unanimously approved by Avanos' Board, is expected to close in the second half of 2026 subject to approvals, after which Avanos will become private and delist from NYSE. No financial performance declines or flat metrics are reported, though standard acquisition risks such as regulatory hurdles and potential termination fees are noted.

• ·Transaction unanimously approved by Avanos’ Board of Directors; not subject to financing condition.
• ·Expected close in second half of 2026, subject to stockholder approval, Hart-Scott-Rodino waiting period, and other regulatory approvals.
• ·Avanos has postponed its 2026 Annual Meeting of Stockholders, previously scheduled for April 21, 2026.
• ·Advisors: J.P. Morgan (lead financial), UBS (financial), Alston & Bird (legal) for Avanos; Sidley Austin (legal), Baker Botts (regulatory) for AIP.

14-04-2026

SeaTown Holdings Pte. Ltd. filed its 13F-HR report for the quarter ended March 31, 2026, disclosing total holdings valued at $152666959 with no changes in share positions from the prior quarter. The portfolio consists of 17 positions across technology, energy, retail, and other sectors, including major holdings in NVIDIA Corporation (94067 shares, $16405285) and Amazon.com Inc. (50100 shares, $10434327). All reported positions remained flat quarter-over-quarter.

• ·Filing filed on April 14, 2026, for period ended March 31, 2026.
• ·Business address: 3 Fraser Street #06-23, Duo Tower, Singapore 189352.
• ·SEC file number: 028-14162.

14-04-2026

AstroNova reported fourth-quarter fiscal 2026 revenue of $37.5 million, up 0.5% YoY in line with guidance, but gross profit declined 7.4% to $11.3 million due to lower volume and mix; full-year revenue was $150.5 million. Net loss narrowed to $1.1 million ($0.15 per diluted share) from $15.6 million YoY, aided by no goodwill impairment, while adjusted EBITDA rose 18.3% to $3.3 million (8.8% margin). Orders grew 6.5% to $41.1 million, operating cash flow was $3.7 million (up from $2.5 million YoY), and debt fell $2.7 million to $37.6 million, though Aerospace revenue decreased 4.1% to $11.2 million.

• ·Product ID aftermarket revenue represented ~80% of segment sales in Q4 FY26.
• ·Aerospace ToughWriter represented >80% of total flight deck printer shipments.
• ·Major royalty obligation expires in Q3 FY27, providing ~$2 million annualized gross profit benefit.
• ·Fiscal 2027 outlook: mid-single digit revenue growth and expanded adjusted EBITDA margin.

14-04-2026

Value Investment Professionals, LLC filed its 13F-HR on April 14, 2026, disclosing 81 equity positions with a total market value of $88,750,853 as of March 31, 2026. No new holdings were added during the quarter, and all positions are held with sole voting and sole dispositive power. Holdings are diversified across individual stocks such as Apple Inc. (11,717 shares), Amazon.com Inc. (6,211 shares), and Microsoft Corp. (3,686 shares), as well as various ETFs including Schwab Strategic TR US REIT ETF (66,112 shares) and WisdomTree TR US High Dividend (266,622 shares).

• ·Filing as of date: April 14, 2026
• ·Report period end: March 31, 2026
• ·Largest share positions by volume: Tandy Leather Factory Inc (183,939 shares), WisdomTree TR US High Dividend (266,622 shares)

14-04-2026

Loar Holdings Inc. (LOAR) filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Stockholders on June 2, 2026, at 10:00 AM ET, held virtually. Key proposals include the election of Class II directors Raja Bobbili, Alison Bomberg, and Margaret (Peg) McGetrick (terms until 2029); ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026; advisory approval of named executive officer compensation; and determining the frequency of future say-on-pay votes. Shareholders must vote by June 1, 2026, 11:59 PM ET, with proxy materials available online at www.ProxyVote.com.

• ·Meeting location: Virtually at www.virtualshareholdermeeting.com/LOAR2026
• ·Proxy materials request deadline: May 19, 2026
• ·Company address: 20 New King Street, White Plains, NY 10604
• ·Vote online at www.ProxyVote.com using control number

14-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 14, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Exhibits), announcing the issuance of a press release titled 'AITX Takes Next Step in Market Structure Evolution with OTCQB Application.' The press release is furnished as Exhibit 99.1. The filing was signed by CEO Steven Reinharz.

• ·Filing Date: April 14, 2026
• ·Date of Earliest Event Reported: April 14, 2026
• ·Principal Executive Offices: 10800 Galaxie Avenue, Ferndale, Michigan, United States 48220
• ·Telephone: (877) 787-6268
• ·State of Incorporation: Nevada
• ·Commission File Number: 000-55079
• ·IRS Employer Identification No.: 27-2343603

14-04-2026

Drive Wealth Management, LLC filed its 13F-HR combination report on April 14, 2026, disclosing equity holdings as of March 31, 2026, including positions managed in conjunction with Towrsquare Capital LLC, Parametric Portfolio Associates LLC, and AQR Capital Management LLC. Notable holdings include large ETF positions such as Capital Group Fixed Income ETF (188,121 shares) and iShares AAA CLO ETF (174,773 shares), alongside individual stocks like Apple Inc. (10,260 shares), Comcast Corp (18,168 shares), and Exxon Mobil Corp (15,751 shares). No total portfolio value, performance metrics, or period-over-period changes are provided in the filing.

• ·Report period end date: March 31, 2026
• ·Business address: 3333 N Digital Drive #700, Lehi, UT 84043
• ·All reported positions held with sole voting and disposition power
• ·Partial list of holdings provided; filing includes ETFs, stocks across sectors

14-04-2026

urban-gro, Inc. entered into a Securities Purchase Agreement dated April 7, 2026, with Agile Hudson Partners LLC for an initial $500,000 First Tranche funding under a convertible Note and accompanying Warrants, exempt from registration under Section 4(a)(2) of the 1933 Act and Rule 506(b). A conditional Second Tranche of $500,000 may follow within 10 trading days of satisfying conditions including the filing of the 10-K for the period ended December 31, 2025, at which point the Note's principal would increase by $549,504.95 (including OID) and accrued interest by $65,940.60. As of April 7, 2026, the Company had 875,600 shares of Common Stock issued and outstanding out of 200,000,000 authorized shares.

• ·Buyer is an accredited investor purchasing Securities for investment, not resale.
• ·Second Tranche Funding Conditions include filing the 10-K with audited financials for fiscal years ended December 31, 2024 and 2025.
• ·Securities subject to restrictive legends until registered or exempt sale under Rule 144, Rule 144A, or Regulation S.

14-04-2026

CGC Financial Services, LLC filed its 13F-HR on April 14, 2026, disclosing total equity holdings of $346,057,622 across 331 positions as of March 31, 2026. The portfolio is heavily weighted toward ETFs, with top holdings including JPMorgan Hedged Equity Laddered Overlay ETF ($69,665,102), Schwab US Dividend Equity ETF ($49,587,952), and JPMorgan Small & Mid Cap Enhanced Equity ETF ($22,671,153). All positions are held solely with full discretionary voting authority and no reported changes from prior periods in this filing.

• ·Filing CIK: 0001992785
• ·SEC File Number: 028-23386
• ·Business Address: 5 Centerpointe Dr, Suite 550, Lake Oswego, OR 97035
• ·All holdings reported as sole discretionary with zero shared or other voting authority

14-04-2026

AMERICAN BATTERY MATERIALS, INC. (BLTH) filed an S-1/A registration statement on April 14, 2026, as part of its IPO process, covering periods through 2025-12-31. The company disclosed significant material weaknesses in its internal control over financial reporting and disclosure controls, including insufficient qualified accounting personnel, lack of segregation of duties, and ineffective handling of complex transactions under U.S. GAAP. These issues raise risks of financial statement errors, potential restatements, and loss of investor confidence impacting stock price, with no offsetting positive financial metrics provided.

• ·Material weaknesses may lead to errors requiring restatements of consolidated financial statements.
• ·Multiple promissory notes, convertible notes, and related-party transactions referenced across 2023-2025 periods.
• ·XBRL tags indicate equity components (Preferred Stock, Common Stock, Additional Paid-In Capital, Retained Earnings) for periods ending 2023-12-31, 2024-12-31, and 2025-12-31.

14-04-2026

Hydrofarm Holdings Group, Inc. entered into a Forbearance Agreement on April 8, 2026, with lenders and FEAC Agent, LLC following a Specified Event of Default for failing to pay interest due January 31, 2026, on its $125,000,000 senior secured Term Loan. The forbearance period runs until April 30, 2026 (extendable), during which the company must maintain at least $1,000,000 in average daily cash, provide budgets and asset sale term sheets, and adhere to strict covenants amid liquidity concerns. An accompanying Amendment No. 2 replaced JPMorgan with FEAC as administrative and collateral agent and imposed additional reporting requirements.

• ·Event of Default notice issued February 11, 2026
• ·Forbearance termination possible upon new Events of Default, non-compliance with requirements, or breaches of representations
• ·Company must present at least two asset valuation bids and a cash flow projection approved by Financial Advisor

14-04-2026

Alphega Innovations Corp reported a significantly widened net loss of $1,176,593 for the three months ended February 28, 2026, up 92% YoY from $613,208, driven by elevated expenses including consulting ($140,250), legal fees ($840,729), and a $144,666 loss on settlement, with no revenue generated. Total liabilities rose 46% QoQ to $3,261,023 as of February 28, 2026, mainly from a $887,148 increase in due to related parties to $2,768,740, deepening the stockholders' deficit to $(3,254,302). Cash balance improved modestly 225% QoQ to $6,721, supported by $40,000 in related party financing amid $35,349 cash used in operations.

• ·Basic and diluted weighted average shares outstanding: 14,749,666 (2026) vs 14,670,000 (2025)
• ·Common stock issued for services: $160,740 (adjustment in cash flow from operations, 2026)
• ·Short term business loan unchanged at $17,000 QoQ
• ·No cash flows from investing activities in either period
• ·Entity is a small business and emerging growth company per filing

14-04-2026

JIA Investment Alliance Pte. Ltd., a Singapore-based investment manager, filed its Form 13F-HR for the period ending March 31, 2026, disclosing total holdings valued at $955,547,069 across 24 equity positions, all with sole voting power. Top holdings include Alphabet Inc. at $129,114,440 (449,000 shares), Microsoft Corp. at $95,622,314 (258,320 shares), and Apple Inc. at $94,333,743 (371,700 shares). No prior period comparisons or changes in holdings are provided in the filing.

• ·Filing submitted on April 14, 2026, for quarter ended March 31, 2026
• ·Former company name: GuoLine Advisory Pte Ltd (changed February 21, 2023)
• ·Business address: 1 Wallich Street #31-01, Guoco Tower, Singapore 078881
• ·All reported holdings have sole voting power (SH SOLE); zero shared or other voting power

14-04-2026

JPMorgan Chase & Co. reported first-quarter 2026 net income of $16.5 billion ($5.94 per diluted share), up 13% YoY, with managed net revenue of $50.5 billion, up 10% YoY, driven by record Markets revenue of $11.6 billion (+20% YoY) and strong growth in CIB (+19% revenue) and AWM (+11% revenue). However, noninterest expense increased 14% YoY to $26.9 billion, provision for credit losses was $2.5 billion, and Corporate net revenue declined 47% YoY to $1.2 billion. ROE was 19% and ROTCE 23%, with CET1 ratio at 14.3% standardized.

• ·#1 ranking for Global Investment Banking fees with 9.8% wallet share in Q1 2026
• ·Investment Banking fees $2.9 billion, up 28% YoY
• ·AUM $4.8 trillion, up 16% YoY; client investment assets up 18% YoY
• ·Common dividend $1.50 per share; book value per share $128.38, up 8% YoY
• ·$72B credit for consumers, $8B for U.S. small businesses, $750B for corporations in Q1 2026
• ·Active mobile customers up 7% YoY; debit and credit card sales volume up 9% YoY

14-04-2026

BHAV Acquisition Corp, a blank check company (SPAC), announced on April 14, 2026, that commencing on or about April 16, 2026, holders of its units (BHAVU) may elect to separately trade the underlying Class A ordinary shares (BHAV) and rights (BHAVR) on the Nasdaq Global Market. Units not separated will continue trading under BHAVU, with brokers required to contact Continental Stock Transfer & Trust Company for separation; no fractional rights will be issued. This follows the company's IPO registration statement effective March 18, 2026, underwritten by Maxim Group LLC.

• ·Each unit consists of one Class A ordinary share, par value $0.0001, and one right to acquire one-fourth of one Class A ordinary share upon initial business combination.
• ·Company focused on advanced and industrial robotics, electric vehicles, drones, unmanned aerial systems, or financial technology sectors.
• ·IPO registration statement on Form S-1 declared effective by SEC on March 18, 2026.

14-04-2026

Dow Inc. held its 2026 Annual Meeting of Stockholders on April 9, 2026, where all 12 director nominees were re-elected for one-year terms and stockholders approved all other proposals, including an advisory resolution on executive compensation, one-year frequency for future say-on-pay votes, amendment to the 2019 Stock Incentive Plan, and ratification of Deloitte & Touche LLP as independent auditor for 2026. Following the meeting, the Board declared a quarterly dividend of 35 cents ($0.35) per share, payable June 12, 2026, to shareholders of record on May 29, 2026, marking the 459th consecutive dividend. The company operates manufacturing sites in 29 countries, employs approximately 34,600 people, and delivered sales of approximately $40 billion in 2025.

• ·Meeting webcast replay available on Dow’s website.
• ·Biographies for directors and committee assignments available on Corporate Governance website.

14-04-2026

On April 8, 2026, Bridget Ross notified LeMaitre Vascular, Inc. of her intent not to stand for re-election as a Class II director at the June 2, 2026 Annual Meeting, continuing to serve until her term expires then; her decision is unrelated to any disagreement with the Company. The Board nominated David B. Roberts to replace her as a Class II director, with Mr. Roberts agreeing to resign his Class I directorship contingent on his election, also unrelated to disagreements. This rebalancing reduces the Board size from eight to seven members effective upon Ms. Ross's departure.

• ·Post-Annual Meeting Board composition: two Class I directors, two Class II directors, three Class III directors.
• ·David B. Roberts notified Board of conditional resignation on April 9, 2026.

14-04-2026

BayBridge Capital Group, LLC filed its 13F-HR on April 14, 2026, disclosing $161398213000 in total equity holdings across 95 positions as of March 31, 2026, all with sole voting and disposition power. Top holdings include iShares Core U.S. Aggregate Bond ETF ($26053065000), Vanguard Total Stock Market ETF ($9226008000), SPDR S&P 500 ETF Trust ($7150029000), iShares Core S&P Mid-Cap ETF ($6311025000), and NVIDIA Corporation ($3853600000). The portfolio shows heavy allocation to bond and broad market ETFs alongside technology stocks, with no quarter-over-quarter changes reported in this snapshot.

• ·All holdings reported with sole voting power (SH SOLE) and no shared power
• ·Filer CIK: 0001898297, based in Livermore, CA
• ·No put/call options or other investment discretion reported

14-04-2026

Creative Realities reported strong Q4 FY2025 revenue growth to $23.9 million from $11.0 million YoY, driven by the CDM acquisition contributing $13.6 million, with gross profit rising to $11.5 million and Adjusted EBITDA to $5.2 million from $0.5 million. However, the company posted a net loss of $2.0 million (improved from $2.8 million YoY), operating expenses increased significantly due to acquisition-related costs, and debt rose to $44.0 million from $13.0 million. ARR reached $20.1 million, up from $12.3 million at Q3 end, with CDM integration on track and $6.4 million in cost synergies realized.

• ·Hardware revenue $6.6M in Q4 FY2025 vs $3.9M prior year.
• ·Service revenue $17.3M in Q4 FY2025 vs $7.2M prior year.
• ·G&A expenses $8.9M in Q4 FY2025 vs $4.2M prior year (incl. $1.2M one-time).
• ·Sales and marketing expenses $2.0M in Q4 FY2025 vs $1.4M prior year.
• ·Operating income $0.5M in Q4 FY2025 vs operating loss $0.7M prior year.
• ·Total assets $151.0M as of Dec 31, 2025 vs $65.2M Dec 31, 2024.

14-04-2026

California Bancorp filed Definitive Additional Proxy Materials (DEFA14A) on April 14, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. This supplements their proxy statement but contains no financial metrics, performance data, or material disclosures.

• ·Filing checkbox: Filed by the Registrant
• ·Payment of Filing Fee: No fee required

14-04-2026

R.H. Investment Group, LLC filed its 13F-HR on April 14, 2026, disclosing 45 equity positions totaling $129662551 as of March 31, 2026, all held as sole discretionary shares with no reported options activity. Top holdings by value include Walmart Inc. ($7999509), Philip Morris Intl Inc. ($7085283), Alphabet Inc. CAP STK CL C ($7029718), Mastercard Inc. CL A ($6386162), and Johnson & Johnson ($6329258). The portfolio spans large-cap stocks across sectors like consumer staples, technology, healthcare, and energy, along with several iShares and Vanguard ETFs.

• ·All 45 positions reported as SOLE discretionary with 0 put options and 0 call options.
• ·No changes from prior quarter indicated (change count: 0).
• ·Filer located at 7373 E. Doubletree Ranch Road, Suite 200, Scottsdale, AZ 85258.
• ·Report conformed period: 03-31-2026; filed as of 04-14-2026.

14-04-2026

American State Bank (Iowa) filed a 13F-HR disclosing $149,054,402 in total holdings value across 122 positions as of March 31, 2024. Top holdings include NVIDIA Corporation ($10.9M), iShares Russell 1000 Growth ETF ($8.0M), Microsoft Corp ($5.8M), and Invesco QQQ Trust ($6.9M), with significant allocations to ETFs and blue-chip stocks. No period-over-period changes are provided in this snapshot filing.

• ·Holdings consist entirely of sole voting authority positions (no shared or other authority indicated).
• ·Significant ETF exposure including multiple iShares and SPDR funds.
• ·Filing covers period ending March 31, 2024, submitted April 14, 2026.

14-04-2026

The Federal Home Loan Bank of Chicago filed an 8-K disclosing consolidated obligation bonds and discount notes committed to be issued on trade dates April 8-10, 2026, for which it is the primary obligor, with total par value of $230 million and maturities ranging from October 2026 to April 2046. Instruments include fixed constant rate bonds at coupons of 4.000% to 5.500% and a variable single index floater, primarily with optional principal redemption features. This is routine disclosure of debt securities backed jointly by the eleven Federal Home Loan Banks, regulated by the FHFA.

• ·All listed consolidated obligations exclude discount notes with maturity of one year or less issued in ordinary course.
• ·Schedule A reports principal at par, which may differ from GAAP financial statement amounts due to discounts, premiums, or concessions.
• ·Consolidated obligations are joint and several obligations of the eleven Federal Home Loan Banks, not guaranteed by U.S. government.

14-04-2026

Nova Wealth Management, Inc. filed a 13F-HR report disclosing total equity holdings of $153,542,097 across 545 positions as of March 31, 2026. The portfolio is diversified with a focus on ETFs and stocks, including top holdings such as Amazon.com Inc. ($1,260,717), iShares Morningstar Growth ETF ($167,09), and iShares Morningstar Mid-Cap Growth ETF ($805,581). No period-over-period changes are available in this filing.

• ·All reported holdings are under sole ownership/discretion.
• ·Filing submitted from Bonita Springs, FL.

14-04-2026

Northrim BanCorp, Inc. issued Definitive Additional Proxy Materials (DEFA14A) for its 2026 Annual Meeting of Shareholders, to be held virtually on May 28, 2026, at 9:00 AM Alaska Daylight Time. Shareholders will vote on Proposal 1: election of twelve director nominees; Proposal 2: first amendment to the 2025 Stock Incentive Plan to add non-employee directors; Proposal 3: non-binding advisory vote on named executive officer compensation; and Proposal 4: ratification of Baker Tilly US, LLP as independent auditors for fiscal year 2026, with the Board recommending a FOR vote on all proposals. Proxy materials and the 2025 Annual Report on Form 10-K are available online at www.proxyvote.com and www.northrim.com.

• ·Virtual meeting access: www.virtualshareholdermeeting.com/NRIM2026 (requires 16-digit Control Number)
• ·Fiscal year for 10-K: ended December 31, 2025
• ·Contact for hard copies: Corporate Secretary, P.O. Box 241489, Anchorage, AK 99524-1489; phone (907) 562-0062; fax (907) 562-1758

14-04-2026

On April 14, 2026, the Board of Directors of Ohio Valley Banc Corp. declared a quarterly cash dividend of $0.25 per common share. The dividend is payable on May 10, 2026 to shareholders of record on April 24, 2026. No comparative dividend amounts or performance metrics were provided in the filing.

• ·Trading symbol: OVBC on NASDAQ
• ·Filing under Item 8.01 Other Events